SLC11A2 and hemochromatosis type 1: In the present study we compared RBCIU after oral with RBCIU after intravenous iron administration in the same subject, demonstrating that both iron mucosal uptake (via DMT1) and mucosal transfer (via ferroportin) were increased in patients with iron deficiency anemia, primary and secondary hemochromatosis.